Breath Analysis in Clinical Trials

Cumulative number of clinical trials involving breath analysis

Analysis of all clinical trial data¹ shows that between 1997 and 2017, 517 trials have used or are using a form of breath analysis in their workflow. During this time period there has been a rise in the annual number of clinical trials starting involving breath analysis, indicating the increasing interest in the utility of breath-based biomarkers (Figure 1).

Disease categorization in 517 clinical trials using breath analysis

The identified clinical trials cover a wide range of conditions, demonstrating the breadth of applications where breath analysis is thought to be useful. A breakdown of the generalized disease categories of the trials is shown in Figure 2.

Download the list of clinical trials involving breath analysis as an excel spreadsheet:

DOWNLOAD TRIALS

The world's largest breath based clinical trials

Owlstone Medical’s Breath Biopsy platform is being used in large clinical trials relating to multiple cancer types including lung cancer, colorectal cancer, as well as asthma (learn more). It is also already used in more than 100 academic research groups and clinical labs around the world.

Breath Biopsy^®

If you want to learn more about how Owlstone Medical's Breath Sampling and Analysis technology and Services are being utilized in early detection and precision medicine, why not download our free ebook: Breath Biopsy: The Complete Guide?

References

1. Data from https://clinicaltrials.gov/.